Catalyst Pharmaceuticals Inc (CPRX)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	398,204	348,393	302,949	256,480	214,203	191,755	170,465	153,717	140,833	133,539	126,902	120,142	119,073	118,181	119,761	118,994	102,306	72,683	41,786	12,948
Total assets	US$ in thousands	470,114	413,211	443,896	407,227	375,630	333,114	267,309	246,972	237,788	223,248	209,130	197,216	192,354	174,860	131,412	117,880	112,376	96,691	78,234	61,077
Total asset turnover		0.85	0.84	0.68	0.63	0.57	0.58	0.64	0.62	0.59	0.60	0.61	0.61	0.62	0.68	0.91	1.01	0.91	0.75	0.53	0.21

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $398,204K ÷ $470,114K
= 0.85

The total asset turnover ratio for Catalyst Pharmaceuticals Inc has experienced fluctuations over the past few quarters. The ratio measures the company's ability to generate sales from its assets.

In the most recent quarter, the total asset turnover was 0.85, indicating that the company generated $0.85 in revenue for every $1 of assets. This represents an increase from the previous quarter's ratio of 0.84, suggesting improved efficiency in asset utilization.

Looking further back, the total asset turnover ratio has shown some variability. In the earlier quarters of the data provided, the ratio ranged between 0.21 and 1.01. This indicates some inconsistency in the company's ability to effectively utilize its assets to generate revenue.

Overall, the upward trend in the most recent quarter is a positive sign for Catalyst Pharmaceuticals Inc, showing improved efficiency in asset utilization. However, the company should continue to monitor and optimize its asset turnover to ensure sustained growth and profitability.